HKSE:06938 (China)
Â
Ordinary Shares - Class H
HK$
54.15
-2.3 (-4.07%)
Sep 11
Business Description
Suzhou Ribo Life Science Co Ltd
ISIN : CNE100007DS6
Share Class Description:
HKSE:06938: Ordinary Shares - Class HTotal Employee Number:
404Compare
Compare
Traded in other countries / regions
06938.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2026-01-09Description
Suzhou Ribo Life Science Co Ltd is a biopharmaceutical company engaged in oligonucleotide R&D, with a focus on siRNA therapeutics. The company's pipeline focuses on cardiovascular, metabolic, renal and liver diseases. Its pipeline includes RBD4059, RBD5044, RBD7007, RBD1119, RBD3103, SR122, SR126, RBD1016, SR112/SR113, among others. It has one reportable operating segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.19 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | -9.27 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.17 | |||||
Beneish M-Score | -3.07 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | -28.89 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 26.46 | |||||
9-Day RSI | 38.34 | |||||
14-Day RSI | 44.41 | |||||
3-1 Month Momentum % | 6.6 | |||||
6-1 Month Momentum % | -7.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.28 | |||||
Quick Ratio | 5.15 | |||||
Cash Ratio | 4.79 | |||||
Days Inventory | 705.63 | |||||
Days Sales Outstanding | 17.85 | |||||
Days Payable | 256.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 94.46 | |||||
Operating Margin % | -5.53 | |||||
Net Margin % | -34.84 | |||||
EBITDA Margin % | -12.67 | |||||
FCF Margin % | -59.8 | |||||
OCF Margin % | -57.76 | |||||
ROE % | -30.5 | |||||
ROA % | -10.58 | |||||
ROIC % | -3.14 | |||||
ROC (Joel Greenblatt) % | -34.21 | |||||
ROCE % | -8.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 16.94 | |||||
PB Ratio | 4.62 | |||||
Price-to-Tangible-Book | 4.81 | |||||
EV-to-EBIT | -77.65 | |||||
EV-to-EBITDA | -107.86 | |||||
EV-to-Revenue | 13.66 | |||||
EV-to-FCF | -22.85 | |||||
| Price-to-Net-Current-Asset-Value | 5.62 | |||||
| Price-to-Net-Cash | 6.74 | |||||
Earnings Yield (Greenblatt) % | -1.29 | |||||
FCF Yield % | -3.48 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Suzhou Ribo Life Science Co Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 534.896 | ||
| EPS (TTM) (HK$) | -1.159 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 44.41 | ||
| 14-Day ATR (HK$) | 4.127664 | ||
| 20-Day SMA (HK$) | 58.315 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 43.6 - 95.8 | ||
| Shares Outstanding (Mil) | 169.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Suzhou Ribo Life Science Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Suzhou Ribo Life Science Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Suzhou Ribo Life Science Co Ltd Frequently Asked Questions
What is Suzhou Ribo Life Science Co Ltd(HKSE:06938)'s stock price today?
The current price of HKSE:06938 is HK$54.15. The 52 week high of HKSE:06938 is HK$95.80 and 52 week low is HK$43.60.
When is next earnings date of Suzhou Ribo Life Science Co Ltd(HKSE:06938)?
The next earnings date of Suzhou Ribo Life Science Co Ltd(HKSE:06938) is .
Does Suzhou Ribo Life Science Co Ltd(HKSE:06938) pay dividends? If so, how much?
Suzhou Ribo Life Science Co Ltd(HKSE:06938) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers